Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia

Authors:

Abstract
No abstract available
Funding Information
  • Novo Nordisk
  • Biotechnology and Biological Sciences Research Council (BB/W000989/1)
  • Biotechnology and Biological Sciences Research Council (BB/P01867X/1)